Tetanus: A review on always severe infectious disease;Le tétanos: Mise au point sur une pathologie infectieuse grave toujours d'actualité

Antibiotiques

Volumn 6, Issue 1 I, 2004, Pages 23-28

  Larroche, Claire ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Clostridium tetani; Specific imunoglobulins; Tetanic anatoxin; Tetanus; Toxin; Vaccination

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; GAMMATETANOS; IMMUNOGLOBULIN; LABETALOL; MAGNESIUM; MAGNESIUM SULFATE; METRONIDAZOLE; MIDAZOLAM; MORPHINE; PENICILLIN G; SEDATIVE AGENT; TETANUS TOXIN; TETANUS TOXOID; TETRACYCLINE DERIVATIVE;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIBODY SPECIFICITY; ANTICOAGULANT THERAPY; ASSISTED VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; CLOSTRIDIUM TETANI; DEBRIDEMENT; DEVELOPED COUNTRY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSAUTONOMIA; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; INTENSIVE CARE; MORTALITY; MUSCLE SPASM; NONHUMAN; PROGNOSIS; REVIEW; TETANUS; TREATMENT OUTCOME;

EID: 1542345051     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1294-5501(04)94229-x     Document Type: Review

References (30)

1. Debord T, Lapeyre E. Tétanos. Encycl Méd Chir (Paris-France), Maladies Infectieuses, 8-038-G-10, Urgences, 24-135-A-10, 1995.
2. Poulain B. Molecular mechanism of action of tetanus toxin and botulinum neurotoxins. Pathol Biol (Paris) 1994 ; 42 : 173-82.
3. Cook TM, Protheroe RT, Handel JM. Tetanus : a review of the literature. Br J Anaesth. 2001 ; 87 : 477-87.
4. Kerr JH, Corbett JL, Prys-Roberts C, et al. Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet 1968 ; 7562 : 236-41.
5. Mazzei DE Davila CA, Davila DF, Donis JH, et al. Autonomic nervous system dysfunction in children with severe tetanus : dissociation of cardiac and vascular sympathetic control. Braz J Med Biol Res 2003 ; 36 : 815-9.
6. Antona D. Le tétanos en France en 2000 et 2001. Bulletin Épidémiologique Hebdomadaire no 40/2002 : 197-9.
7. Dyce O, Bruno JR, Hong D, et al. Tongue piercing. The new« rusty nail » ? Head Neck 2000 ; 22 : 728-32.
8. Abrahamian FM, Pollack CV JR, Lovecchio F, et al. Fatal tetanus in a drug abuser with « protective » antitetanus antibodies. J Emerg Med 2000 ; 18 : 189-93.
9. Bunch TJ, Thalji MK, Pellikka PA, et al. Respiratory failure in tetanus : case report and review of a 25-year experience. Chest 2002 ; 122 : 1488-92.
10. Mollaret P, Vic-Dupont, Cartier F, et al. Treatment of tetanus in the resuscitation center of the Hospital Claude-Bernard. Information gathered from the 150 most recent cases in a statistical series of 1,000 patients Presse Med 1965 ; 73 : 2153-6.
11. De La Chapelle A, Lavabre O, Pinsard M, et al. Tetanus in a renal transplant recipient exhibiting the presence of circulating antitetanus antibodies determined by ELISA. Biomed Pharmacother 2002 ; 56 : 208-10.
12. Thwaites CL, Farrar JJ. Preventing and treating tetanus. BMJ 2003 ; 326 : 117-8.
13. Pedalino B, Cotter B, Ciofi Degli Atti M, et al. Epidemiology of tetanus in Italy in years 1971-2000. Euro Surveill 2002 ; 7 : 103-10.
14. Bulletin des maladies évitables par la vaccination, OMS/AFRO, no 024 juin 2002.
15. Trujillo MH, Castillo A, Espana J, et al. Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases. Chest 1987 ; 92 : 63-5.
16. Ahmadsyah I, Salim A. Treatment of tetanus : an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J 1985 ; 291 : 648-50.
17. Blake PA, Feldman RA, Buchanan TM, et al. Serologic therapy of tetanus in the United States, 1965-1971. JAMA 1976 ; 235 : 42-4.
18. Reddy VG. Pharmacotherapy of tetanus a review. Middle East J Anesthesiol 2002 ; 16 : 419-42.
19. Mukherjee DK. Tetanus and tracheostomy. Ann Otol Rhinol Laryngol 1977 ; 86 : 67-72.
20. Aydin K, Caylan R, Caylan R, et al. Otolaryngologic aspects of tetanus. Eur Arch Otorhinolaryngol 2003 ; 260 : 52-6.
21. Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus : a prospective study of 40 patients. Anaesthesia 2002 ; 57 : 811-7.
22. Wesley AG, Hariparsad D, Father M, et al Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia 1983 ; 38 : 243-9.
23. Mayorga C, Torres MJ, Corzo JL, et al. Immediate allergy to tetanus toxoid vaccine : determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann Allergy Asthma Immunol 2003 ; 90 : 238-43.
24. Mcquillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002 ; 136 : 660-6.
25. Riazi A, Odelin MF, Lery L, et al. Réponse vaccinale par l'anatoxine tétanique chez la femme âgée : étude prospective sur 42 mois. Méd Mal Infect 1999 ; 29 : 619-25.
26. Schatz D, Ellis T, Ottendorfer E, et al. Aging and the immune response to tetanus toxoid : diminished frequency and level of cellular immune reactivity to antigenic stimulation. Clin Diagn Lab Immuno 1998 ; 5 : 894-6.
27. Roué R, Rapp C. Prevention of tetanus. Rev Prat 2002 ; 52 : 877-80.
28. Direction Générale de la Santé Comité technique des vaccinations. Guide des vaccinations, édition 1999.
29. Cassell OC. Death from tetanus after a pretibial laceration. BMJ 2002 ; 324 : 1442-3.
30. De La Coussaye JE, Elkharrat D, Maslo C, et al. Prise en charge du risque de tétanos devant une plaie de l'adulte. Enquête nationale après des urgentistes. Laboratoire français du fractionnement et des biotechnologies, mai 2003.